<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_EPFL_Description_Lysates_Catalog skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:EPFL/Description/Lysates/Catalog</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV id="apta-menu-bar"><P style="float:right; color:white; padding-right:60px;padding-top:10px;" class="apta-menu-icon"><B>MENU</B></P></DIV><DIV class="apta-wrapper"><DIV class="apta-menu-item"><UL><LI class="main-submenu-item"><A href="https://2017.igem.org/Team:EPFL">Home</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Project</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Description">Overview</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Summary">Results overview</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Outlook">Outlook</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Team</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Team">Our team</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Attributions">Attributions</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Collaborations">Collaborations</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Human practices</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/HP">Overview</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/HP/Mini-Kit">Educational CF Kit- Description</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/HP/Mini-Kit/Storyline">Educational CF Kit - The Project</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Lysates</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Description/Lysates">Description</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Results/Lysates">Results</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Description/Lysates/Catalog">Catalog</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Aptamers</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Parts/Description">Description</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Description/Aptamers">Microfluidics</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Results/Aptamers">Microfluidics - Results</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Description/Beads">Beads</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Results/Aptamers2">Beads - Results</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Toehold</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Description/Toehold">Description</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Results/Toehold">Results- Trigger Modularity</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Results/Toehold/Signal_Generation">Results - Signal Generation</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Software</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Software">Description</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Software/Demo">Results</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Lab</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Safety">Safety</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Protocols">Protocols</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Notebook">Notebook</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Parts">Parts</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Medal requirements</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Attributions">Attributions</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Collaborations">Collaborations</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Contribution">Contribution</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/HP/Silver">Silver</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/HP/Gold_Integrated">Gold Integrated</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Demonstrate">Proof of Concept</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Improve">Improvement</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Prizes</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Engagement">Education &amp; Public Engagement</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Software">Software</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Applied_Design">Applied Design</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/HP/Gold_Integrated">Integrated Human Practices</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Contact</LI><LI class="sec-submenu-item">epfl.igem2017@gmail.com</LI><LI class="sec-submenu-item"><I><A href="https://www.facebook.com/igemepfl/?fref=ts" class="fa fa-facebook fa-2x">facebook</A></I></LI><LI class="sec-submenu-item"><I><A href="https://twitter.com/epfl_igem?lang=en" class="fa fa-twitter fa-2x">twitter</A></I></LI></UL></DIV></DIV><DIV class="content-description"><DIV class="part-content"><DIV class="title"> Lysate catalog </DIV><P> In the following we list the characteristics of the cell lysates we produced in our labaratory for the purposes of improving cell lysates characterization and finding the most suited lysates for our detection tool. </P><P> For supporting information, click <A href="https://www.thermofisher.com/ch/en/home/life-science/cloning/competent-cells-for-transformation/chemically-competent/dh5alpha-genotypes.html">here</A>.</P><DIV class="subtitle"> BL21(DE3) Lysate </DIV><UL class="middle"><LI> Organism: E. coli  </LI><LI> Strain: BL21(DE3)  </LI><LI> Bacterial strain supplier: Novagen<A href="#1"><SUP>1</SUP></A></LI><LI> Genotype: F-ompT hsdSB(rB-mB-) gal dcm (DE3)</LI><LI> Polymerase(s):
	</LI><LI>	E.coli RNA polymerase</LI></UL><UL><LI>	T7 RNA polymerase (gene under control of the lacUV5 promoter induced by IPTG)</LI></UL><LI>	Antibiotic Resistances:	</LI><LI>	None</LI><LI>	Comments:
	</LI><LI>	Engineered for transformation and high protein expression</LI><UL><LI>	Deficient in Ion and ompT protease</LI></UL><UL><LI>	 T7 RNA polymerase expression when induced with IPTG</LI></UL><DIV class="subtitle"> M15 Lysate </DIV><UL class="middle"><LI>Organism: E. coli</LI><LI>Strain: E. coli M15 DZ291</LI><LI>Bacterial strain supplier: Qiagen<A href="#2"><SUP>2</SUP></A></LI><LI>Genotype: F- Φ80ΔlacM15 thi lac- mtl- recA+KmR</LI><LI>Polymerase(s):
        </LI><LI>E. coli RNA polymerase</LI></UL><LI>Antibiotic Resistances:
        </LI><LI>Kanamycin </LI><LI>Comments:
        </LI><LI>Deficiency in lacZα </LI><LI>blue-white screening or complementation of β-galactosidase</LI><DIV class="subtitle"> T7-M15 Lysate </DIV><UL class="middle"><LI>Same characteristics as M15 strain</LI><LI>M15 strain transformed with plasmid pQE30 with the T7 RNA polymerase gene inserted between BamH1 and HindIII restriction sites<A href="#3"><SUP>3</SUP></A></LI><LI>Polymerase(s):
         </LI><LI>E. coli RNA polymerase</LI><LI>T7 RNA polymerase</LI></UL><LI> Antibiotic Resistance:
        </LI><LI>Ampicillin</LI><LI>Kanamycin</LI><LI> Comments:
         </LI><LI>T7 RNA polymerase expression when induced with IPTG </LI><DIV class="subtitle"> DH5α </DIV><UL class="middle"><LI>Organism: E. coli</LI><LI>From: Thermofisher<A href="#4"><SUP>4</SUP></A></LI><LI>Strain: DH5α™ T1R </LI><LI>Genotype: F– Φ80lacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 thi-1 gyrA96 relA1 tonA</LI><LI>Polymerase(s):
        </LI><LI>E. coli RNA polymerase </LI></UL><LI>Resistances:
        </LI><LI>None</LI><LI>Comments:
        </LI><LI>Resistance to T1 and T5 phage</LI><LI>Deficiency in lacZα </LI><LI>blue-white screening or complementation of β-galactosidase</LI><DIV class="subtitle"> Top10 </DIV><UL class="middle"><LI>Organism: E. coli	</LI><LI>From: Invitrogen<A href="#5"><SUP>5</SUP></A></LI><LI>Strain: TOP10</LI><LI>Genotype: F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 Δ lacX74 recA1 araD139 Δ(araleu)7697 galU galK rpsL (StrR) endA1 nupG</LI><LI>Polymerase(s):
        </LI><LI>E. coli RNA polymerase</LI></UL><LI>Resistances:
        </LI><LI>None</LI><LI>Comments:
        </LI><LI>Deficiency in lacZα </LI><LI>blue-white screening or complementation of β-galactosidase</LI><DIV class="subtitle"> Top10-gams </DIV><UL class="middle"><LI>Organism: E. coli</LI><LI>From: Invitrogen <A href="#6"><SUP>6</SUP></A></LI><LI>Strain: TOP10</LI><LI>Genotype: F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 Δ lacX74 recA1 araD139 Δ( araleu)7697 galU galK rpsL (StrR) endA1 nupG</LI><LI>Polymerase(s):
        </LI><LI>E. coli RNA polymerase</LI></UL><LI>Resistances:
        </LI><LI>Ampicillin</LI><LI>Comments:
        </LI><LI>Deficiency in lacZα </LI><LI>blue-white screening or complementation of β-galactosidase</LI><LI>Plasmid pBADmod1-linker2-gamS<A href="#7"><SUP>7</SUP></A>  is inserted in top10 competent cells to produce gamS</LI><LI>Respectively T7 RNA polymerase and gamS protein expression when induced with IPTG and arabinose</LI></DIV><H2 class="top-space bottom-space"><CENTER><SMALL>References</SMALL></CENTER></H2><P id="1" class="cit">1. http://www.merckmillipore.com/CH/fr/product/BL21%28DE3%29-Competent-Cells---Novagen,EMD_BIO-69450#anchor_Description</P><P id="2" class="cit">2. https://www.qiagen.com/fr/resources/resourcedetail?id=73e1f246-204e-47a8-8a9c-b8a808870c2a&amp;lang=en</P><P id="3" class="cit">3. Shimizu, Yoshihiro, et al. &quot;Cell-free translation reconstituted with purified components.&quot; Nature biotechnology 19.8 (2001).</P><P id="4" class="cit">4. https://www.thermofisher.com/order/catalog/product/12297016?SID=srch-srp-12297016</P><P id="5" class="cit">5. https://www.thermofisher.com/order/catalog/product/C404010</P><P id="6" class="cit">6. https://www.thermofisher.com/order/catalog/product/C404010</P><P id="7" class="cit">7. http://www.addgene.org/45833/
</P></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>